Alzheimer’s Disease Drug

Global and China Alzheimer’s Disease Drug Market Research by Company, Type & Application 2013-2025

Report ID: HeyReport 34929 | Number of pages: 80 | Publish Date: Aug 2019 | Category: Lifesciences and Healthcare 
Summary
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
Market Segment as follows:
By Type
    Donepezil
    Memantine
    Rivastigmine
By Application
    Early to Moderate Stages
    Moderate to Severe Stages
By Company
    Lundbeck.
    Merz Pharma
    Eisai
    Daiichi Sankyo
    Johnson & Johnson
    Novartis
    Allergan
    Pfizer
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Interested in this report?
Get your sample now!
Download Sample 
Table of Content
1 Market Overview
    1.1 Market Segment Overview
        1.1.1 Product Definition
        1.1.2 Market by Type
            1.1.2.1 Donepezil
            1.1.2.2 Memantine
            1.1.2.3 Rivastigmine
        1.1.3 Market by Application
            1.1.3.1 Early to Moderate Stages
            1.1.3.2 Moderate to Severe Stages
    1.2 Global and China Market Size
        1.2.1 Global Overview
        1.2.2 China Overview
2 Global and China Market by Company
    2.1 Global
        2.1.1 Global Sales by Company
        2.1.2 Global Price by Company
    2.2 China
        2.2.1 China Sales by Company
        2.2.2 China Price by Company
3 Global and China Market by Type
    3.1 Global
        3.1.1 Global Sales by Type
        3.1.2 Global Price by Type
    3.2 China
        3.2.1 China Sales by Type
        3.2.2 China Price by Type
4 Global and China Market by Application
    4.1 Global
        4.1.1 Global Sales by Application
        4.1.2 Global Price by Application
    4.2 China
        4.2.1 China Sales by Application
        4.2.2 China Price by Application
5 China Trade
    5.1 Export
    5.2 Import
6 Key Manufacturers
    6.1 Lundbeck.
        6.1.1 Company Information
        6.1.2 Product Specifications
        6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    6.2 Merz Pharma
    6.3 Eisai
    6.4 Daiichi Sankyo
    6.5 Johnson & Johnson
    6.6 Novartis
    6.7 Allergan
    6.8 Pfizer
7 Industry Upstream
    7.1 Industry Chain
    7.2 Raw Materials
8 Market Environment
    8.1 SWOT
    8.2 Porter's Five Forces
9 Conclusion
Figure Donepezil Market Size and CAGR 2013-2018 (Million USD)
Figure Donepezil Market Size and CAGR 2013-2018 (Volume)
Figure Donepezil Market Forecast and CAGR 2019-2025 (Million USD)
Figure Donepezil Market Forecast and CAGR 2019-2025 (Volume)
Figure Memantine Market Size and CAGR 2013-2018 (Million USD)
Figure Memantine Market Size and CAGR 2013-2018 (Volume)
Figure Memantine Market Forecast and CAGR 2019-2025 (Million USD)
Figure Memantine Market Forecast and CAGR 2019-2025 (Volume)
Figure Rivastigmine Market Size and CAGR 2013-2018 (Million USD)
Figure Rivastigmine Market Size and CAGR 2013-2018 (Volume)
Figure Rivastigmine Market Forecast and CAGR 2019-2025 (Million USD)
Figure Rivastigmine Market Forecast and CAGR 2019-2025 (Volume)
Figure Early to Moderate Stages Market Size and CAGR 2013-2018 (Million USD)
Figure Early to Moderate Stages Market Size and CAGR 2013-2018 (Volume)
Figure Early to Moderate Stages Market Forecast and CAGR 2019-2025 (Million USD)
Figure Early to Moderate Stages Market Forecast and CAGR 2019-2025 (Volume)
Figure Moderate to Severe Stages Market Size and CAGR 2013-2018 (Million USD)
Figure Moderate to Severe Stages Market Size and CAGR 2013-2018 (Volume)
Figure Moderate to Severe Stages Market Forecast and CAGR 2019-2025 (Million USD)
Figure Moderate to Severe Stages Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Alzheimer’s Disease Drug Market Size and CAGR 2013-2017 (Million USD)
Figure Global Alzheimer’s Disease Drug Market Size and CAGR 2013-2017 (Volume)
Figure Global Alzheimer’s Disease Drug Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global Alzheimer’s Disease Drug Market Forecast and CAGR 2019-2025 (Volume)
Figure China Alzheimer’s Disease Drug Market Size and CAGR 2013-2017 (Million USD)
Figure China Alzheimer’s Disease Drug Market Size and CAGR 2013-2017 (Volume)
Figure China Alzheimer’s Disease Drug Market Forecast and CAGR 2019-2025 (Million USD)
Figure China Alzheimer’s Disease Drug Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Alzheimer’s Disease Drug SWOT List
Figure Alzheimer’s Disease Drug Porter's Five Forces